Company	Market Cap (₹in Cr.)	P/E (x)	P/B(x)	EV / EBITDA(x)	Dividend Yield(%)	EPS
Cipla Ltd	113,109.96	39.61	2.89	5313.67	0.93	35.35
Sun Pharmaceutical Indust..	426,121.89	122.06	18.85	6053.68	0.9	14.55
Divis Laboratories Ltd	266,424.27	88.93	9.43	3921	0.3	112.85
Torrent Pharmaceuticals L..	179,914.00	92.33	16.9	4001.11	0.71	51.23
Laurus Labs Ltd	124,601.40	119.24	10.19	1515.69	0.09	19.34

More >

Return Calculator

This tools helps you project your potential return on investments for the given stock, for a specified amount over a per-defined period of time.

If I had made investment of ₹ Returns(%)

in Months Ago

My investment would be worth₹ with a Loss of

Share Holding

CATEGORY	NO. OF SHARES	PERCENTAGE (%)
Total Foreign	173177195	21.44
Total Institutions	281494092	34.84
Total Govt Holding	25467	0.00
Total Non Promoter Corporate Holding	3120246	0.39
Total Promoters	235287003	29.12
Total Public & others	114766612	14.21
Total	807870615	100

Total Foreign
Total Institutions
Total Govt Holding
Total Non Promoter Corporate Holding
Total Promoters
Total Public & others

Research Reports

DATE	TITLE
11-Oct-2019 10:18 PM	Indian Oil Corporation (1QFY20): Petchem to shine out. Maintain BUY
11-Oct-2019 10:18 PM	Materials (Oil & Gas, Chemicals): 1QFY20E Results Preview
11-Oct-2019 10:18 PM	Sector Technical Report - Nifty PSE Index - 070919
11-Oct-2019 10:18 PM	Sector Technical Report - Nifty Metal Index

More >

Corporate Actions

More >

About Company

Cipla Limited is one of the leading pharmaceutical companies in India. The Company is in the business of manufacturing, developing, and marketing wide range of branded and generic formulations and Active Pharmaceutical Ingredients (APIs). Cipla's product portfolio spans complex generics as well as drugs in the respiratory, anti-retroviral, urology, cardiology, anti-infective, CNS, and various other key therapeutic segments. With a rich portfolio, it is deepening presence in the home markets of India, as well as South Africa, North America, and other key regulated and emerging markets. Its 48 manufacturing sites around the world produce more than 50 dosage forms and over 1,500 products across wide range of therapeutic categories.

Cipla Limited was incorporated in year 1935 with the name as 'Chemical, Industrial & Pharmaceutical Laboratories Limited'. Khwaja Abdul Hamied, the founder of Cipla gave the company all his patent and proprietary formulas for several drugs and medicines, without charging any royalty. On August 17, 1935, Cipla was registered as a public limited company with an authorized capital of Rs 6 lakh. From its first manufacturing unit at Bombay Central in 1936, Cipla now has over 40 state-of-the art manufacturing facilities across the globe including India, USA...

More >